Whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as application of liquid biopsy testing, across biofluids, biomarkers and disease indications, as the needle shifts on the gold standard of personalized healthcare testing.
Liquid Biopsy: New Opportunities, Technologies, and Challenges in the Field
Isolating & evaluating CFNAS
Exploring extracellular vesicles
Circulating Tumour DNA
Clinical biomarker detection sensitivity and accuracy
Isolating & analyzing CTCS
Methelation & Fragmentomics
Hotspot mutations in liquid biopsies
Exploring biofluids, & biomarkers Applications
Liquid Biopsy - Material standardization for quality control
Directors, VPs, Managers and Heads of:
Liquid biopsy
Clinical Pathology
Molecular Assay Development
Medical Laboratory
Scientific Affairs
Sales and Marketing
Quality Management
Process Development
Commercial & Outreach, Oncology
Molecular pathology
Research Scientist
Molecular Biology
Precision medicine
Immunochemistry
Pharmacology
Biotech
